Eric R. Olson
2023
In 2023, Eric R. Olson earned a total compensation of $935.8K as Former Chief Scientific Officer at Syros Pharmaceuticals, a 44% decrease compared to previous year.
Compensation breakdown
| Salary | $409,791 |
|---|---|
| Stock Awards | $140,700 |
| Other | $385,277 |
| Total | $935,768 |
Olson received $409.8K in salary, accounting for 44% of the total pay in 2023.
Olson also received $140.7K in stock awards and $385.3K in other compensation.
Rankings
In 2023, Eric R. Olson's compensation ranked 1,149th out of 2,314 executives tracked by ExecPay. In other words, Olson earned more than 50.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,149 out of 2,314 | 50th |
Division Manufacturing | 680 out of 1,250 | 46th |
Major group Chemicals And Allied Products | 450 out of 705 | 36th |
Industry group Drugs | 439 out of 676 | 35th |
Industry Pharmaceutical Preparations | 306 out of 490 | 38th |
Source: SEC filing on April 23, 2024.
Olson's colleagues
We found one more compensation record of an executive who worked with Eric R. Olson at Syros Pharmaceuticals in 2023.
2023
Nancy Simonian
Syros Pharmaceuticals
Chief Executive Officer
News
Syros Pharmaceuticals CEO Nancy Simonian's 2023 pay falls 59% to $1.4M
April 23, 2024
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019